0% found this document useful (0 votes)
165 views1 page

Pfizer SWOT PDF

Pfizer is a large pharmaceutical company founded in 1849 that discovers, develops, manufactures and markets patented pharmaceuticals and generic drugs in over 100 countries. A SWOT analysis found strengths in Pfizer being the world's largest drugmaker by revenue and focus on R&D, weaknesses in calls to split the company and past reliance on acquisitions, and opportunities in personalized medicine and emerging markets, but also threats from healthcare reform and further price cuts in key markets.

Uploaded by

Rachel
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
165 views1 page

Pfizer SWOT PDF

Pfizer is a large pharmaceutical company founded in 1849 that discovers, develops, manufactures and markets patented pharmaceuticals and generic drugs in over 100 countries. A SWOT analysis found strengths in Pfizer being the world's largest drugmaker by revenue and focus on R&D, weaknesses in calls to split the company and past reliance on acquisitions, and opportunities in personalized medicine and emerging markets, but also threats from healthcare reform and further price cuts in key markets.

Uploaded by

Rachel
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1

Healthcare – Pfizer Analysis

Company Overview
Founded in 1849, New York City-based Pfizer discovers, develops, manufactures and markets
patented pharmaceuticals, generic drugs and consumer health products. The company employs
approximately 110,000 people and is present in over 100 countries.

SWOT Analysis

Strengths
The world's largest drugmaker in terms of revenue. A focus on R&D to drive growth.

Weakness
Investor calls to split the company into two entities. Previous over-reliance on inorganic
growth.

Opportunities
Greater involvement in personalised medicine. Increasing penetration of emerging markets.

Threats
Increased contribution to US healthcare reform. Further medicine price cuts in Europe.

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy